Jasper Therapeutics Target Price

Analysts' average 12-month price target for Jasper Therapeutics is $2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.63

Average Target Price

$2.00

217.5% upside

1 analysts in the last 4 months

High: $2 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-12	Piper SandlerBiren Amin	$2	217.5% upside
2026-05-15	RBC Capital	$3	376.2% upside
2025-01-09	RBC CapitalGregory Renza	$48	7519% upside
2024-12-05	BMO CapitalEtzer Darout	$63	9900% upside
2024-05-06	H.C. WainwrightEmily Bodnar	$65	10217.5% upside
2024-04-03	Evercore ISIGavin Clark-Gartner	$65	10217.5% upside
2023-02-07	Cantor Fitzgerald	$6	852.4% upside
2023-01-11	Credit Suisse	$3	376.2% upside

Jasper Therapeutics (JSPR) FAQ

Jasper Therapeutics posts a target price of $2. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $2 for JSPR means covering analysts, on average, see the stock 217.5% upside of $0.63 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for JSPR's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Jasper Therapeutics's other metric pages and overview cover the third.